AAV microinjection of mutant tau (Tau‐P301L) to forebrain organoids induces pronounced tau aggregates containing tau fibrils, which could overcome the limitation of tauopathy recapitulation in the very early disease stage [161]. Here, MAPT is linked to tauopathy.